Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Net Cash Flow (2021 - 2025)

Senti Biosciences has reported Net Cash Flow over the past 5 years, most recently at $4.2 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 88.97% year-over-year to $4.2 million; the TTM value through Dec 2025 reached -$31.9 million, down 357.68%, while the annual FY2025 figure was -$31.9 million, 357.68% down from the prior year.
  • Net Cash Flow for Q4 2025 was $4.2 million at Senti Biosciences, up from -$9.3 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $101.7 million in Q2 2022 and troughed at -$57.2 million in Q4 2022.
  • A 5-year average of -$1.9 million and a median of -$6.4 million in 2023 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 9167.98% in 2022 and fell as far as 6537.26% in 2022.
  • Year by year, Net Cash Flow stood at $889323.0 in 2021, then crashed by 6537.26% to -$57.2 million in 2022, then surged by 88.86% to -$6.4 million in 2023, then skyrocketed by 692.08% to $37.8 million in 2024, then tumbled by 88.97% to $4.2 million in 2025.
  • Business Quant data shows Net Cash Flow for SNTI at $4.2 million in Q4 2025, -$9.3 million in Q3 2025, and -$12.2 million in Q2 2025.